Case Report: Dupilumab Successfully Controls Severe Eczema in a Child With Elevated IgE Levels and Recurrent Skin Infections

The efficacy of dupilumab in pediatric patients with severe eczema presenting in the setting of elevated immunoglobulin E (IgE) levels and recurrent bacterial skin infections is not well-understood. Here we present the case of a child with elevated IgE levels in whom dupilumab treatment led to remar...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Tejas P., Anvari, Sara, Gupta, Meera R., Davis, Carla M., Hajjar, Joud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511520/
https://www.ncbi.nlm.nih.gov/pubmed/34660469
http://dx.doi.org/10.3389/fped.2021.646997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511520/
https://www.ncbi.nlm.nih.gov/pubmed/34660469
http://dx.doi.org/10.3389/fped.2021.646997

Ejemplares similares